MDNAMedicenna Therapeutics Corp.

OTC http://www.medicenna.com/


$ 0.16 $ 0.16 (88.14 %)    

Wednesday, 01-Nov-2023 15:19:39 EDT
QQQ $ 432.61 $ 1.56 (0.36 %)
DIA $ 378.92 $ -0.49 (-0.13 %)
SPY $ 505.41 $ 0.66 (0.13 %)
TLT $ 88.53 $ 0.42 (0.48 %)
GLD $ 221.50 $ 1.64 (0.75 %)
$ 0.333
$ 0.19
$ 0.00 x 0
$ 0.00 x 0
$ 0.16 - $ 0.19
$ 0.15 - $ 0.84
4,823
na
96.1M
$ 1.74
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX:MDNA, OTC:MDNAF), a clinical-stage immunothera...

Core News & Articles

Company's T-MASK platform demonstrates ability to maximize anti-tumor efficacy and minimize systemic toxicity, and opportun...

 why-biophytis-shares-are-trading-higher-by-over-12-here-are-20-stocks-moving-premarket

Gainers

 why-barnes-group-shares-are-trading-lower-by-around-28-here-are-other-stocks-moving-in-fridays-mid-day-session

Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.

 nasdaq-jumps-100-points-amazon-posts-upbeat-earnings

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Friday. Following the...

Core News & Articles

New data from the Phase 1 dose-escalation and evaluation portion of the trial will be presented at the Society of Immunotherapy...

 stocks-that-hit-52-week-lows-on-friday

  Friday's session saw 112 companies set new 52-week lows.

 oppenheimer-maintains-outperform-on-medicenna-therapeutics-lowers-price-target-to-3

Oppenheimer analyst Matthew Biegler maintains Medicenna Therapeutics (NASDAQ:MDNA) with a Outperform and lowers the price ta...

 hc-wainwright--co-reiterates-buy-on-medicenna-therapeutics-maintains-25-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Medicenna Therapeutics (NASDAQ:MDNA) with a Buy and mainta...

 stocks-that-hit-52-week-lows-on-wednesday

  On Wednesday, 155 companies set new 52-week lows.

Core News & Articles

- Durable anti-cancer activity was observed during monotherapy dose escalation without dose-limiting toxicities   - Late-stage...

 earnings-scheduled-for-august-9-2023

Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on r...

 medicenna-granted-us-patent-number-11680090-titled-interleukin-2-fusion-proteins-and-uses-thereof

Medicenna Therapeutics Corp. has been granted U.S. Patent No. 11,680,090 titled "Interleukin-2 Fusion Proteins and Uses The...

 hc-wainwright--co-reiterates-buy-on-medicenna-therapeutics-maintains-25-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Medicenna Therapeutics (NASDAQ:MDNA) with a Buy and mainta...

 hc-wainwright--co-reiterates-buy-on-medicenna-therapeutics-maintains-25-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Medicenna Therapeutics (NASDAQ:MDNA) with a Buy and mainta...

NEW CASE INVESTIGATION